Most people who use marijuana report that consuming before or after exercising improves the experience and aids in recovery, according to a new study. And those who do use cannabis to elevate their workout tend to get a healthier amount of exercise.
Researchers at the University of Colorado surveyed more than 600 marijuana consumers in states where it is legal to assess how people use cannabis in relation to exercise. Their results, published this month in the journal Frontiers in Public Health, poke yet another hole in the lazy, couch-locked stoner stereotype.
Almost 500 participants said they endorse using marijuana one hour before, or up to four hours after, exercising. And based on data from the questionnaire, those who did use cannabis in that timeframe worked out longer than consumers who didn’t pair the activities. Specifically, those who engaged in co-use worked out an average of 43 minutes longer for aerobic exercise and 30 minutes longer for anaerobic exercise.
What’s behind the trend?
There are a few known barriers to exercise that researchers have identified: a lack of motivation, difficult recovery after working out and low enjoyment of the activity. Cannabis seems to help lift those barriers for some individuals.
Seventy percent of respondents said they agree or strongly agree that “cannabis increases enjoyment of exercise,” 78 percent said that marijuana “enhances recovery from exercise” and just over 50 percent said that it “increases motivation.”
“To our knowledge, this is the first study to survey attitudes and behavior regarding the use of cannabis before and after exercise, and to examine differences between cannabis users who engage in co-use, compared to those who do not,” the study authors wrote. “Given both the spreading legalization of cannabis and the low rates of physical activity in the US, it behooves public health officials to understand the potential effects—both beneficial and harmful—of cannabis use on exercise behaviors.”
While it might seem counterintuitive given how cannabis consumers have typically been portrayed in media, there’s a growing body of research showing that many marijuana enthusiasts engage in active lifestyles and that cannabis is associated with positive health outcomes. For example, another recent study found that people who use marijuana are less likely to be obese compared to non-users.
Photo courtesy of Brian Shamblen.
Dogs Treated With Cannabis Oil Experience Less Frequent Seizures, Study Finds
Dogs with epilepsy experience considerably fewer seizures when treated with CBD oil, a new study published in the journal Pet Behaviour Science found.
The small study—which followed three dogs receiving hemp-derived CBD treatment over the course of two months, indicates that dogs respond to the cannabis compound in a way that’s similar to humans.
The dogs ranged in age and breed. One was a three-year-old Labrador Retriever that suffered seizures spaced out one month apart on average, another was an 11-year-old Papillon that experienced seizures every two to three months and the last was a 10-year-old Chihuahua that has infrequent seizures about twice a year.
For the experiment, each dog was treated with CBD twice a day on an empty stomach. The findings are based on reports from the owners, two out of three of whom said the treatment improved their dog’s condition. The Papillon’s owner said the dog’s condition was unchanged.
“The owner [of the Labrador Retriever] reported that the dog slept longer and barked less in the daytime, even when other dogs were excited, during the first two weeks than in the preceding weeks,” the study authors wrote. “Overall, the owner felt that the dog showed improvement.”
“The owner [of the Chihuahua] felt that seizure-like behavior during the attacks had decreased slightly with treatment,” they wrote. “The owner also reported that the dog showed less aggression toward familiar people, such as the owner’s children.”
While the sample size of the study is particularly small, making it difficult to draw broad conclusions, the researchers said “seizure frequency improved considerably and owners reported a positive impression” of the CBD treatment.
It’s not clear if the same biochemical mechanisms that make CBD an effective treatment for epilepsy in humans produced the effects in the dogs. It’s possible that, because seizures can be triggered by anxiety, the same “anxiolytic effect may attenuate the symptoms of epilepsy in dogs as well as humans.”
“Further research is needed for better understanding the neurobiological mechanisms of CBD treatment,” the researchers wrote.
Last year, a separate study determined that CBD can alleviate the symptoms of osteoarthritis in dogs.
Photo courtesy of Pexels.
Another Federal Agency Wants You To Stop Calling About A Marijuana-Related Job
Six days after posting a notice that calls for a contractor to prepare and distribute research drug products like marijuana cigarettes, a federal agency posted an update, emphasizing that private citizens are not being encouraged to apply for a casual joint-rolling job.
Why? Well, it might have something to do with various viral articles reporting on the opening—and readers who then volunteer for the role.
On Monday, the National Institute on Drug Abuse (NIDA) added an unambiguous message at the top of the notice: “THE FOLLOWING IS A PRE-SOLICITATION NOTICE and is NOT ADVERTISEMENT FOR EMPLOYMENT.”
The situation seems similar to another recent example that prompted the Houston division of the Drug Enforcement Administration (DEA) to ask private citizens to stop calling about a contractor opening to incinerate thousands of pounds of cannabis per hour.
The division wrote last month that “misleading articles” about the position “resulted in an influx of calls from citizens.”
Several recent misleading articles alleging #DEAHouston is looking for Houstonians to burn Marijuana have resulted in an influx of calls from citizens. This solicitation was targeted for a large scale licensed vendor, not private citizens. https://t.co/GSygqBBWKB
— DEAHouston (@DEAHOUSTONDiv) March 29, 2019
“This solicitation was targeted for a large scale licensed vendor, not private citizens,” they wrote.
But according to NIDA, their problem isn’t quite as severe. In an email to Marijuana Moment, a representative of the agency said it has “only received a few public inquiries.” The spokesperson did not respond to a follow up question about the reasoning behind the update.
For serious candidates, the position isn’t as simple as rolling a massive amount of joints. The contractor must have “the capability to analyze and characterize various drugs of abuse including cannabinoids and other research chemicals” and also “acquire, develop, and produce marijuana and nicotine research cigarettes of varying strengths and specifications.”
Photo courtesy of Philip Steffan.
Federally Produced Marijuana Is Closer To Hemp Than Commercial Cannabis, Study Shows
Research-grade marijuana that’s supplied by the only federally authorized cultivation site in the United States is genetically closer to hemp than cannabis varieties sold at dispensaries in legal states, according to a new study.
The revelation raises questions about how applicable the results of research using the government marijuana really are to understanding the effects of products that consuming are actually using.
Previous studies have demonstrated that marijuana that’s grown at the University of Mississippi, with funding from the National Institutes On Drug Abuse (NIDA), has lower levels of THC and CBD compared to commercial cannabis products. But researchers at the University of Northern Colorado wanted to learn specifically about their genetic variance.
The study, which was made available as a preprint on bioRxiv, looked at 49 different cannabis samples, including hemp and NIDA-supplied marijuana, as well as various indica, sativa and hybrid strains sold in the commercial market. When the samples were genetically analyzed, the researchers were surprised to find just how different NIDA’s marijuana is from the cannabis most people are consuming.
As has already been established, marijuana and hemp proved to be genetically distinct. But interestingly, research-grade cannabis from NIDA shared a closer “genetic affinity with hemp samples in most analyses” than with commercially available marijuana, the study authors wrote.
“Our genetic investigation adds to this previous research, indicating that the genetic makeup of NIDA Cannabis is also distinctive from commercially available medical and recreational Cannabis,” they wrote. “To our knowledge, this is the first genetic study to include research-grade marijuana from NIDA, and its placement with hemp samples was unexpected.”
The findings raise concerns about the results of federally approved marijuana research that has relied on the NIDA supply. If the research concerned individual components of cannabis such as THC and CBD, the samples might be useful, but study participants who consume the NIDA varieties may be experiencing different effects than patients and consumers that get their marijuana from dispensaries.
“As the interest for medical Cannabis increases, it is important that research examining the threats and benefits of Cannabis use accurately reflect the experiences of the general public,” the researchers wrote.
Advocates, scientists and lawmakers have already been urging the Justice Department to expand the number of federally authorized marijuana manufacturing facilities, arguing that the limited supply and diversity of cannabis varieties available from the government’s current sole source is hindering research, but the approval process has been slow-moving.
Whether it will speed up under new Attorney General William Barr is yet to be determined, but he has voiced support for such expansion and said in January that he would “review the matter and take appropriate steps.”
Photo courtesy of WeedPornDaily.